Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion. - Lin YX; Liu H; Liao WC; Wang YC; Zhang BC; Wan SW; Chen CC; Chang CP (Oncology reports, 2025)